These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8438397)

  • 21. Leflunomide, a novel immunomodulatory agent: in vitro analyses of the mechanism of immunosuppression.
    Chong AS; Gebel H; Finnegan A; Petraitis EE; Jiang XL; Sankary HN; Foster P; Williams JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):747-9. PubMed ID: 8438466
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug-drug interaction between cyclosporine and agents affecting calcium-dependent lymphocyte proliferation.
    Colombani PM; Bright EC; Wells M; Hess AD
    Transplant Proc; 1989 Feb; 21(1 Pt 1):840-1. PubMed ID: 2705246
    [No Abstract]   [Full Text] [Related]  

  • 23. Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis.
    Koenen HJ; Michielsen EC; Verstappen J; Fasse E; Joosten I
    Transplantation; 2003 May; 75(9):1581-90. PubMed ID: 12792519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of immunosuppressive drugs on cytokine gene transcription studied by message amplification phenotyping (MAPPing) polymerase chain reaction.
    Nelson PA; Kawamura A; Akselband Y; Peattie DA; Aldape RA; Harding MW
    Transplant Proc; 1991 Dec; 23(6):2867-9. PubMed ID: 1721299
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacology of calmodulin and kinase C antagonists.
    Hidaka H
    Proc West Pharmacol Soc; 1986; 29():187-9. PubMed ID: 3763607
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro expression of activation markers and lymphocyte proliferation in response to interleukin 12: effect of immunosuppressive agents.
    Degiannis D; Koniavitou K
    Transplant Proc; 1996 Dec; 28(6):3062-4. PubMed ID: 8962187
    [No Abstract]   [Full Text] [Related]  

  • 27. Species- and gender-related differences in cyclosporine/prednisolone/sirolimus interactions in whole blood lymphocyte proliferation assays.
    Ferron GM; Jusko WJ
    J Pharmacol Exp Ther; 1998 Jul; 286(1):191-200. PubMed ID: 9655860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein kinase C inhibitors, H7 and calphostin C, inhibit induction of DNA synthesis by cytosolic extracts of exponentially growing neuroblastoma cells in isolated nuclei.
    Miñana MD; Cabedo H; Felipo V; Grisolía S
    Brain Res; 1994 Dec; 667(2):161-6. PubMed ID: 7535173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FK 506 and rapamycin do not affect platelet aggregation or mitochondrial function.
    Pelekanou V; Trezise AE; Moore AL; Kay JE
    Transplant Proc; 1991 Dec; 23(6):3200-1. PubMed ID: 1721408
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of the proliferation of human thymocytes in vitro by rapamycin.
    Miller GA; Bansbach CC; Rabin M
    Transplantation; 1992 Oct; 54(4):763-5. PubMed ID: 1412778
    [No Abstract]   [Full Text] [Related]  

  • 31. Delayed tyrosine phosphorylation and nuclear expression of STAT1 following antigen receptor stimulation of B lymphocytes.
    Karras JG; Huo L; Wang Z; Frank DA; Zimmet JM; Rothstein TL
    J Immunol; 1996 Sep; 157(6):2299-309. PubMed ID: 8805627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phorbol 12-myristate 13-acetate and serum synergize to promote rapamycin-insensitive cell proliferation via protein kinase C-eta.
    Martin PM; Aeder SE; Chrestensen CA; Sturgill TW; Hussaini IM
    Oncogene; 2007 Jan; 26(3):407-14. PubMed ID: 16832347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The inhibition of T-cell-receptor-induced Fas ligand upregulation by cyclosporine and FK 506.
    Nakajima H; Oka T
    Transplant Proc; 1996 Apr; 28(2):1052-5. PubMed ID: 8623224
    [No Abstract]   [Full Text] [Related]  

  • 34. Route of administration determines the efficacy of rapamycin but not the mechanisms of tolerance induced by it in rats.
    Lin Y; Rutgeerts O; Waer M
    Transplant Proc; 1996 Dec; 28(6):3057. PubMed ID: 8962185
    [No Abstract]   [Full Text] [Related]  

  • 35. The protein kinase C inhibitor H-7 inhibits concanavalin A induced T-lymphocyte activation.
    Xu H; Fan SG; Lee CM
    Gen Pharmacol; 1989; 20(5):585-8. PubMed ID: 2606326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activators of protein kinase C but not of phospholipase C modulate adenylate cyclase-responses of normal pig epidermis.
    Iizuka H; Takahashi H; Ishida-Yamamoto A; Hashimoto Y
    Epithelial Cell Biol; 1995; 4(1):35-41. PubMed ID: 8563794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The in vivo effect of rapamycin derivative SDZ RAD on lymphocyte proliferation.
    Böhler T; Waiser J; Budde K; Lichter S; Jauho A; Fritsche L; Korn A; Neumayer HH
    Transplant Proc; 1998 Aug; 30(5):2195-7. PubMed ID: 9723438
    [No Abstract]   [Full Text] [Related]  

  • 38. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
    Hess DA; Bird IA; Almawi WY; Rieder MJ
    J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic interactions of cyclosporine and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitro.
    Kahan BD; Gibbons S; Tejpal N; Stepkowski SM; Chou TC
    Transplantation; 1991 Jan; 51(1):232-9. PubMed ID: 1987692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1-Oleolyl-2-glycerol stimulates immunoglobulin production in human peripheral blood mononuclear cells independent of T-cell activation.
    Yamaguchi DT; Jordan SC; Sakai R
    Transplant Proc; 1989 Feb; 21(1 Pt 1):203-4. PubMed ID: 2784893
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.